Staphylococcus aureus is not a dog's bacteria. It's a human bacteria that dogs occasionally acquire from close contact with people who carry it.

This distinction from S. pseudintermedius, the far more common canine staph, explains almost everything about how dogs get S. aureus infections, who is most at risk, and how the infections behave.

Quick answer: Staphylococcus aureus is a bacterium primarily found on human skin and in human nasal passages. It can infect dogs through close contact with human carriers, but it is far less common in dogs than S. pseudintermedius. When it becomes methicillin-resistant (MRSA), it cannot be treated with standard beta-lactam antibiotics. Most dogs with MRSA either clear it without symptoms or develop skin, wound, or ear infections similar in appearance to MRSP. Culture and sensitivity testing is required for diagnosis and treatment guidance.

Key takeaways

• S. aureus is not normal dog flora: it colonizes humans, not dogs, and reaches dogs via human contact.
• MRSA in dogs is uncommon: S. pseudintermedius causes the majority of resistant canine staph infections.
• Therapy dogs and dogs in healthcare households have the highest MRSA exposure risk.
• MRSA symptoms in dogs are identical to MRSP: culture is the only way to distinguish them.
• Both MRSA and susceptible S. aureus can clear spontaneously in healthy dogs without causing infection.
• Treatment requires culture-guided antibiotic selection: same principle as MRSP.

S. aureus vs S. pseudintermedius: the fundamental difference

The two most clinically relevant staph species in dogs are Staphylococcus pseudintermedius and Staphylococcus aureus. They are related but biologically distinct, with very different host preferences.

Texas A&M Veterinary Medical Teaching Hospital confirms: "S. aureus (and thus MRSA) primarily causes bacterial infections in people, while S. pseudintermedius (and thus MRSP) is predominantly a bacterial pathogen of dogs and cats."

How dogs get S. aureus

Because S. aureus is not part of normal dog skin flora, dogs don't develop it independently. They acquire it from human sources.

Primary transmission routes:

• Direct contact with a human carrier or infected person: approximately 33% of healthy humans carry S. aureus in their nasal passages; of those, approximately 2% carry MRSA. Petting, hugging, or sharing sleeping spaces with a colonized person transfers bacteria.
• Healthcare-associated exposure: therapy dogs that visit hospitals, nursing homes, or rehabilitation centers are directly exposed to environments with high MRSA concentrations. WagWalking confirms: "Therapy dogs that visit hospitals and nursing homes are at a higher risk of being exposed to MRSA."
• Household healthcare workers: dogs whose owners work in hospitals, nursing homes, or clinical settings have elevated MRSA exposure through the owner's occupational carriage.
• Contaminated environments: bedding, surfaces, and objects contaminated by MRSA-positive humans can transfer bacteria to dogs.

PetMD confirms: "Dogs more commonly get methicillin-resistant S. pseudintermedius (MRSP). MRSA in dogs is rare. MRSA is much more common in people."

What S. aureus infection looks like in dogs

Colonized dogs (no symptoms)

Many dogs who acquire S. aureus from human contacts never develop clinical infection. Their immune system and skin barrier prevent the bacteria from establishing disease. These dogs are "colonized" carriers.

PetMD: "When dogs have MRSA, they may not show signs of illness. Their immune system may readily clear the bacteria without any issues. Dogs that carry the bacteria on their skin without any symptoms of infection are referred to as 'colonized.'"

Infected dogs

When S. aureus does cause clinical infection, the signs are identical to S. pseudintermedius infection:

• Non-healing or slow-healing wounds or skin lesions
• Redness, swelling, and warmth at the wound or lesion site
• Pus-like or yellow-green discharge
• Wound not improving despite antibiotic treatment
• Foul odor from the affected area

WagWalking notes: "S. aureus commonly affects the skin and other soft tissues, resulting in abscesses or skin infections. It rarely affects the joints, eyes, ears, or urinary tract."

Signs requiring emergency assessment:

• Lethargy, loss of appetite, and fever together (signs of sepsis)
• Rapid spreading of redness or swelling
• Dog is immunocompromised and any of the above

Which dogs are most at risk

Immunocompromised dogs

PetMD: "Pets who become sick from MRSA are usually those who are immunocompromised, meaning they are either very young, very old, or have underlying disease, wounds, or a recent surgery."

Healthy dogs with intact skin and functional immunity routinely clear S. aureus exposure without developing infection. The risk of clinical infection rises sharply when immune defenses are reduced.

Higher-risk groups:

• Puppies (immature immunity)
• Senior dogs (reduced immune function)
• Dogs with recent surgery or open wounds
• Dogs with diabetes, Cushing's, or chronic skin disease
• Dogs on long-term immunosuppressive medications

Dogs with human exposure routes

• Therapy dogs with regular hospital visits
• Dogs in households where someone has an active S. aureus or MRSA infection
• Dogs in households where someone works in healthcare

For the broader context of how resistant staph infections compare in dogs, see resistant staph comparison.

Diagnosis

You cannot distinguish S. aureus infection from S. pseudintermedius infection by looking at the wound or lesion. Both present identically.

Definitive diagnosis requires:

1. Bacterial culture of the wound, lesion, ear canal, or skin swab
2. Species identification (speciation confirms aureus vs. pseudintermedius: this requires the lab to speciate; request it specifically if not automatic)
3. Methicillin resistance testing (confirms MRSA status)
4. Full sensitivity panel (identifies which drugs retain activity)

For how resistant staph is diagnosed in general, see resistant staph diagnosis.

Treatment

For susceptible S. aureus

Susceptible S. aureus responds to standard beta-lactam antibiotics:

• Cephalexin
• Amoxicillin-clavulanate
• Cefpodoxime

These first-line options work well for non-resistant S. aureus skin and wound infections.

For MRSA

MRSA is resistant to all beta-lactam antibiotics. Treatment options based on sensitivity results:

• Trimethoprim-sulfonamides: often active against MRSA
• Doxycycline: commonly active; sensitivity must be confirmed
• Clindamycin: if sensitive and no inducible macrolide resistance
• Rifampicin: in combination with another active drug only
• Chloramphenicol: less commonly used for MRSA vs. MRSP but may be active

PetMD specifies options: "rifampin, clindamycin, sulfa trimethoprim, marbofloxacin, vancomycin, amikacin, chloramphenicol, and doxycycline are all examples of systemic antibiotics that may be prescribed based on culture results."

Vancomycin is a last-resort human antibiotic occasionally used in MRSA cases; its use requires infectious disease consultation.

For early-stage staph identification before speciation, see early-stage staph overview. For how dogs typically get staph infections, see how dogs get staph.

Household management when a dog has MRSA

Because MRSA is a human-adapted organism with documented bidirectional transmission, household management is particularly important.

Household precautions:

• Wash hands after every contact with the dog or wound
• Wear gloves during wound care or topical treatment
• Keep infected dogs away from young children, elderly, and immunocompromised household members
• Don't allow the dog to lick faces or open skin
• Disinfect shared surfaces and wash bedding frequently

Texas A&M Vet Hospital guidance: "Keep young children and immunocompromised people (cancer patients, HIV/AIDS, patients receiving immunosuppressive drugs) away from the affected pet."

If MRSA is confirmed, inform any household member's physician, particularly if they are immunocompromised or healthcare workers who may have contributed to transmission.

For zoonotic risk in detail, see zoonotic risk from resistant staph.

Frequently asked questions

How do I know if my dog has MRSA or MRSP?

You cannot tell from appearance alone. Both cause identical skin, wound, and ear infections. Only a bacterial culture with species identification and methicillin resistance testing confirms which organism is present. If your vet only ran cytology (looking at cells under the microscope), culture has not been performed. Ask your vet explicitly about culture and speciation if resistance is suspected.

My dog was diagnosed with MRSA. Does someone in my house have it?

Almost certainly, someone in the household or the dog's regular environment carries S. aureus, possibly MRSA. The dog received the bacteria from a human source, not from another dog or the environment independently. It may be worth discussing with your physician whether household members should be tested, particularly if any of them have had recent skin or wound infections.

Can my dog give MRSA back to me?

Yes. Bidirectional MRSA transmission between dogs and humans is documented. Dogs infected through human contact can shed MRSA back into the household through direct contact or contaminated surfaces. Standard hygiene precautions (handwashing, wound avoidance, gloves for wound care) reduce this risk substantially.

S. aureus in dogs is fundamentally a human story: a human bacterium that reaches dogs through human contact, causes identical-looking infection to S. pseudintermedius, and in its MRSA form creates the same antibiotic resistance challenge. The clinical management is parallel to MRSP: culture, sensitivity testing, targeted antibiotics, topical wound care. What differs is the source, the transmission pattern, and the household implications.*

Resources

• PetMD. Methicillin-Resistant Staphylococcus Aureus in Dogs. petmd.com
• Texas A&M Veterinary Medical Teaching Hospital. MRSA. vetmed.tamu.edu
• WagWalking. Methicillin-Resistant Staphylococcus Aureus in Dogs. wagwalking.com
• MedVet. Methicillin-Resistant Staphylococcus Pseudintermedius (MRSP) in Dogs and Cats. medvet.com

MRSP stands for methicillin-resistant Staphylococcus pseudintermedius. That's a mouthful, but the practical reality is simpler: it's a resistant form of a bacteria that already lives on most dogs' skin, one that has become harder to kill because the antibiotics most vets reach for first no longer work against it.

This guide covers what MRSP is, how dogs get it, what it looks like, how it's confirmed, and what treatment actually requires.

Quick answer: MRSP is a resistant form of Staphylococcus pseudintermedius, the most common bacteria on dog skin. It develops resistance through repeated antibiotic exposure. It causes skin infections, ear infections, and post-surgical wound infections that don't respond to standard antibiotics like amoxicillin or cephalexin. Diagnosis requires bacterial culture and sensitivity testing. Treatment centers on topical chlorhexidine for skin infections and sensitivity-guided systemic antibiotics for deep infections.

Key takeaways

• MRSP is S. pseudintermedius that has become antibiotic-resistant most commonly through prior antibiotic exposure.
• MRSP is different from MRSA MRSP is dog-adapted; MRSA comes from humans.
• Skin infections, ear infections, and surgical wound infections are the most common presentations.
• The key clinical clue is failure to respond to standard antibiotics after 7 to 10 days.
• Culture and sensitivity testing is mandatory there is no other way to confirm MRSP.
• Most dogs with MRSP recover with correct treatment and underlying disease management.

What is MRSP?

Staphylococcus pseudintermedius is a coagulase-positive staph bacterium that colonizes approximately 50% of healthy dogs as normal skin flora. Under normal circumstances it causes no disease. When the skin barrier is damaged (by allergy, wounds, or surgery) or the immune system is reduced, it can establish infection.

MRSP is the methicillin-resistant form of this bacteria. It carries the mecA gene, which produces a modified penicillin-binding protein (PBP2a) that prevents beta-lactam antibiotics from binding to it. This makes all penicillins and cephalosporins ineffective and most MRSP isolates carry additional resistance genes making them resistant to multiple other antibiotic classes as well.

MRSP vs. MRSA:

For a complete comparison, see MRSP and MRSA compared.

How dogs get MRSP

From their own bacteria (most common)

The bacteria responsible for MRSP is already on the dog's skin. Repeated antibiotic courses apply selection pressure, shifting the bacterial population toward resistant organisms. A dog who has had multiple courses of amoxicillin or cephalexin over their lifetime has progressively higher risk of MRSP.

From hospital and kennel environments

Veterinary hospitals, ICUs, and kennels concentrate MRSP from multiple dogs. A Portuguese ICU study found 21.6% of admitted dogs had MRSP, with documented acquisition during hospitalization.

From direct contact with MRSP-positive dogs

Contact with active lesions or contaminated bedding can transfer bacteria between dogs, particularly when the receiving dog has compromised skin.

For the full transmission picture, see how dogs acquire MRSP.

Symptoms of MRSP infection

Skin infections (most common)

MRSP skin infections look identical to routine staph infections initially. The distinguishing feature emerges over time: the infection doesn't improve with standard antibiotics.

What to watch for:

• Pustules (pimple-like bumps) at hair follicle bases
• Epidermal collarettes (circular crusty rings where pustules have burst)
• Patchy hair loss over affected areas
• Redness and mild swelling
• Skin odor that persists or worsens despite treatment
• Persistent itching, licking, or scratching in the affected area

Deeper infections additionally show:

• Painful, firm nodules under the skin
• Draining tracts releasing pus or blood-tinged fluid
• Significant hair loss and skin discoloration

Ear infections

MRSP otitis externa presents with the same signs as routine ear infection head shaking, pawing at ears, ear odor, brown or yellow discharge but does not respond to standard ear medications. Culture of ear discharge is required before treatment.

Post-surgical wound infections

MRSP post-surgical infections typically present between days 5 and 14 after surgery, though implant-associated infections can emerge weeks to months later. Signs include discharge not clearing, wound failing to close, and returning lameness in orthopedic cases.

For MRSP after surgery specifically, see MRSP after surgery.

Systemic signs (serious infection)

If infection spreads beyond skin or wound:

• Fever above 103°F
• Significant lethargy
• Loss of appetite beyond 48 hours
• Vomiting

Systemic signs alongside wound changes require same-day emergency assessment.

Which dogs are most at risk

Higher-risk dogs:

• Dogs with atopic dermatitis, hypothyroidism, or Cushing's disease
• Dogs with prior antibiotic exposure in the past 12 months
• Dogs that have had recent surgery, particularly orthopedic procedures
• Dogs with a history of MRSP infection
• Dogs that visit veterinary hospitals or kennels frequently
• Puppies and elderly dogs with immature or reduced immunity

For immunocompromised dogs specifically, see MRSP in immunocompromised dogs.

Diagnosis

Culture and sensitivity testing

There is no way to diagnose MRSP visually. A wound or skin infection looks the same whether it's caused by susceptible or resistant staph.

Culture and sensitivity testing:

1. Identifies the species (S. pseudintermedius vs. others)
2. Confirms methicillin resistance
3. Identifies which antibiotics retain activity against this isolate

Sample collection:

• Intact pustule: swab the contents directly
• Epidermal collarette: swab under the active edge
• Deep pyoderma: punch biopsy for tissue culture
• Ear: swab otic discharge

When to suspect MRSP

• No improvement after 7 to 10 days on an appropriate antibiotic
• Infection returning within weeks of completing a course
• History of MRSP diagnosis
• Multiple antibiotic courses in the past year

MedVet confirms: "Most pets with MRSP infection are treated successfully."

Treatment

Topical chlorhexidine: the foundation

For all skin infections, topical chlorhexidine shampoo 2 to 4% is the first-line treatment. It is effective regardless of antibiotic resistance because it works through physical membrane disruption, not through binding to cellular targets bacteria can mutate around.

• 5 to 10-minute contact time before rinsing
• 2 to 3 times weekly during active infection
• Once weekly for maintenance in recurrence-prone dogs

Published research: 65.4% of MRSP pyoderma cases resolved with topical therapy alone (PMC4204846).

Systemic antibiotics (when needed)

Added for deep infections, widespread disease, or failure of topical-only therapy. Always based on sensitivity results.

Never for MRSP: amoxicillin, Clavamox, cephalexin, cefpodoxime, or any beta-lactam.

Potentially active options (sensitivity result determines which):

• Chloramphenicol
• Potentiated sulfonamides
• Rifampicin (always in combination)
• Doxycycline (variable activity)
• Amikacin (injectable; severe cases)

For full treatment detail, see how to treat MRSP in dogs.

Managing the underlying cause

Recurrent MRSP without atopy, endocrine disease, or skin fold management will keep returning. Treatment of each infection episode must be paired with management of the trigger.

Prognosis

MedVet: "Most pets with MRSP infection are treated successfully."

The resistance makes treatment more complex but not untreatable. The key factors determining prognosis:

• Whether the underlying disease can be managed
• Whether the sensitivity result identifies an active antibiotic
• Whether the full treatment course is completed
• For post-surgical cases: whether implant removal is feasible if needed

Frequently asked questions

Can my dog spread MRSP to my other dog or to me?

Dog-to-dog spread is possible through direct wound contact but uncommon. Human infection from MRSP is documented but rare for healthy adults; immunocompromised household members are at higher risk. Standard hygiene (handwashing, wound avoidance, gloves during wound care) reduces household risk. Full quarantine is not typically necessary.

My dog was diagnosed with MRSP once. Will every future skin infection also be MRSP?

Not necessarily, but MRSP carrier status can persist for months after infection. Future infections may be MRSP or susceptible staph which is why culture and sensitivity testing before each systemic antibiotic course is important rather than assuming.

Is MRSP the same thing as a "superbug"?

MRSP is resistant to multiple antibiotic classes, which is what earns it the "resistant" label. It is not inherently more virulent than susceptible staph the clinical danger comes from the narrow treatment options, not from the bacteria being biologically more aggressive.

MRSP is a manageable infection with the right approach. Culture before antibiotics. Topical antiseptic as the foundation. Sensitivity-guided systemic treatment when needed. Full course completed past visible healing. Underlying disease addressed. That's the framework.

Resources

• MedVet. Methicillin-Resistant Staphylococcus Pseudintermedius (MRSP) in Dogs and Cats. medvet.com
• Animal Friends Dermatology. MRSP in Dogs and Cats. animalfriendsdermatology.com
• Clinician's Brief. Staphylococcus pseudintermedius: An Overview. cliniciansbrief.com

Pseudomonas aeruginosa is one of the most challenging bacterial pathogens in veterinary medicine. It is everywhere in the environment soil, water, and surfaces but normally causes no problems in healthy dogs. When it establishes infection in the ear, a wound, or damaged skin, it is extraordinarily difficult to eliminate.

The challenge is not just that P. aeruginosa is resistant to many antibiotics. It also forms biofilm a protective matrix that shields bacteria from both antibiotics and the immune system. This combination makes Pseudomonas infections among the hardest infections to treat successfully.

Quick answer: Pseudomonas aeruginosa causes resistant infections in dogs, most commonly in the ear canal, skin, and wounds. Standard antibiotics often fail due to biofilm and intrinsic resistance. Culture testing is essential before treatment.

Key takeaways

• P. aeruginosa is an environmental opportunist: infects dogs when ear, skin, or wound defenses are compromised
• Ear infections are the most common presentation: floppy-eared and swimming breeds are most affected
• Biofilm formation makes P. aeruginosa infections far more resistant to treatment than planktonic (free-floating) bacteria
• 80 to 90% of Pseudomonas otitis cases are difficult to treat with standard antibiotic approaches per published data
• Culture and sensitivity testing is mandatory: empirical antibiotic selection without testing leads to treatment failure
• Fluoroquinolones (marbofloxacin) at high dosing are often the systemic antibiotic of choice when susceptibility testing supports it

What is Pseudomonas aeruginosa?

P. aeruginosa is a Gram-negative, aerobic rod-shaped bacterium that inhabits soil, water, and moist environments. VetInfo: "Pseudomonas aeruginosa are a gram-negative bacteria with the ability to survive in many unexpected situations. They generally thrive in oxygen-rich environments but can also survive and reproduce in anaerobic conditions."

It is ubiquitous but not part of the normal canine ear canal microbiome. MDPI (2023): "P. aeruginosa is not an obligate pathogen, and studies investigating the source of these infections often highlight environmental sources particularly water, although nosocomial infections in veterinary surgery are possible."

Two properties make P. aeruginosa uniquely difficult:

1. Intrinsic antibiotic resistance: P. aeruginosa is naturally resistant to many antibiotic classes, including most penicillins, most cephalosporins, macrolides, tetracyclines, and chloramphenicol. This leaves a narrow therapeutic window even before acquired resistance develops.

2. Biofilm formation: VetCareNews: "P. aeruginosa possesses the ability to create a biofilm a congregation of multiple organisms that adheres to the surface and is protected by a layer." Bacteria within biofilm can be up to 1,000 times more resistant to antibiotics than free-floating bacteria. Biofilm forms in chronic ear infections, on catheter surfaces, and in chronic wounds.

How dogs get Pseudomonas infections

Chronic ear disease and allergy

The most common pathway. Allergic otitis externa creates a chronically inflamed, moist ear canal environment. Normal ear canal bacteria are disrupted, and P. aeruginosa introduced from water or the environment colonizes the damaged tissue.

MDPI (2023, Pseudomonas OE review): "Dysbiosis often makes dogs more vulnerable to ear infections with Pseudomonas, particularly when accompanied by other factors, such as neglect." Allergy is the most common primary factor driving the conditions that allow P. aeruginosa to establish itself.

DVM360: "P. aeruginosa is ubiquitous in the environment but an uncommon inhabitant of the normal external ear canal and middle ear of dogs."

Water exposure

Swimming dogs are at elevated risk. P. aeruginosa thrives in water. Dogs that swim regularly introduce the organism into the ear canal repeatedly, and if the ear canal is already predisposed by allergy or conformation, infection can establish.

Wounds and surgical sites

Damaged skin and surgical incisions particularly those healing slowly or in contaminated environments can be colonized by environmental P. aeruginosa. Hospital-acquired (nosocomial) Pseudomonas wound infections occur in veterinary settings.

Compromised immune system

Dogs on immunosuppressive therapy, with diabetes, or with severe metabolic disease have impaired local and systemic defenses that allow P. aeruginosa to cause infection in sites it would normally not colonize.

Symptoms by infection type

Ear infections (otitis externa and media)

The most common and most recognizable presentation. DVM360: "Animals with P. aeruginosa ear infections typically exhibit one or more of the following clinical signs." VetCareNews lists the range: "depending on the severity, signs can range from discharge, foul odor, or head shaking to severe neurological signs such as head tilt, balance issues, or loss of hearing."

Key distinguishing features of Pseudomonas otitis:

• Extremely foul-smelling discharge often described as one of the most distinctive odors in veterinary medicine (VetInfo: "One of the leading symptoms is a strong odor. Pseudomonas ear infections are extremely smelly with lots of drainage or pus.")
• Green or blue-green discharge (P. aeruginosa can produce pyocyanin, a blue-green pigment)
• Severe pain dogs resist examination; may vocalize when the ear is touched
• Erythema and ulceration of the ear canal lining
• Progressive: if untreated, progresses to otitis media (middle ear) and potentially neurological signs

Breed predisposition: Cocker Spaniels, Basset Hounds, Labrador Retrievers, Golden Retrievers, and other drop-eared or swimming breeds. MDPI: "Certain breeds are predisposed due to factors such as long, pendulous, hairy, or V-shaped drop pinna."

Skin infections (pyoderma)

P. aeruginosa is an uncommon cause of primary pyoderma but a recognized secondary invader in damaged skin. Signs: intensely red, inflamed skin; oozing discharge; foul odor; pain. It often accompanies other bacterial infections (polymicrobial infection).

Wound infections

Post-surgical or traumatic wound infections with P. aeruginosa cause chronic, non-healing wounds with profuse purulent discharge, often with a characteristic odor.

Urinary tract infections

Less common than ear infections. Signs mirror other bacterial UTIs: pollakiuria, stranguria, hematuria. P. aeruginosa UTI typically occurs in dogs with urinary catheters, structural abnormalities, or prior antibiotic use.

Corneal ulcers

Rapid, aggressive progression distinguishes Pseudomonas corneal ulcers from other causes. The ulcer can progress to perforation within hours to days if P. aeruginosa is involved. This is an ophthalmic emergency.

Diagnosis

Ear: cytology (examining discharge under a microscope) confirms bacterial infection and Gram-negative rods suggestive of Pseudomonas. Culture and sensitivity confirms the species and guides treatment.

Wounds and skin: swab culture with sensitivity. Surface swabs may miss the true pathogen in biofilm; deep samples or tissue biopsy may be needed.

Urine: culture with sensitivity from a cystocentesis sample (directly from the bladder).

Critical principle: DVM360: "Make sure your veterinarian runs a culture to check for pseudomonas aeruginosa. If the culture is positive, expect a different treatment plan." Pseudomonas cannot be treated empirically with standard protocols.

Treatment

Why standard antibiotics fail

P. aeruginosa resists most commonly used veterinary antibiotics through multiple mechanisms: outer membrane impermeability (limits drug entry), efflux pumps (actively expel antibiotics from the cell), and beta-lactamase production (destroys beta-lactam antibiotics). Acquired resistance through mutation or gene transfer adds additional layers.

MDPI (otitis study): "The eradication of P. aeruginosa has become increasingly difficult... nearly 24% of treatments of otitis externa cases in dogs are unsuccessful and this is more pronounced if P. aeruginosa is the causative agent, as in these cases, 80 to 90% of cases are untreatable."

Systemic antibiotics

Fluoroquinolones are the primary systemic option when susceptibility is confirmed. DVM360: "I most commonly use marbofloxacin for systemic treatment of Pseudomonas otitis when susceptibility testing indicates susceptibility. I prescribe at the high end of the flexible dosing range 5.5 mg/kg once daily."

Marbofloxacin has pharmacokinetic advantages over other fluoroquinolones for Pseudomonas treatment. Ciprofloxacin has activity but poor oral bioavailability in dogs. Aminoglycosides (gentamicin, tobramycin) are effective but typically used topically due to systemic toxicity concerns.

Topical treatment for otitis

Topical aminoglycosides (gentamicin, tobramycin), polymyxin B, and topical fluoroquinolones are used directly in the ear canal. Achieving therapeutic concentrations topically is generally more feasible than systemically. Thorough ear cleaning before topical application is essential to remove biofilm and pus that would otherwise prevent drug penetration.

Biofilm disruption

Biofilm significantly impairs antibiotic efficacy. N-acetylcysteine, EDTA, and tris-EDTA are ear flush components that help disrupt biofilm structure, allowing antibiotics better access. Regular, thorough ear cleaning is not optional it is a core component of Pseudomonas otitis treatment.

Surgery: total ear canal ablation (TECA)

DVM360: "At this point, the best option is a total ear canal ablation and bulla osteotomy. Thankfully, this is rarely necessary if veterinarians pursue an aggressive diagnostic and therapeutic approach." TECA is reserved for chronic, treatment-resistant cases where the ear canal is severely damaged and stenotic.

For how Pseudomonas contributes to severe wound infections, see irrigation solutions active against Pseudomonas. For how Pseudomonas contributes alongside other resistant organisms in serious infections, see other resistant organisms alongside Pseudomonas. For how antiseptics active against Pseudomonas compare, see antiseptics effective against Pseudomonas. For how Pseudomonas features in severe deep tissue infections, see Pseudomonas in severe infections.

Prevention

• Dry ears thoroughly after swimming or bathing: moisture is the primary environmental setup for P. aeruginosa colonization
• Manage allergies aggressively: allergy is the most common underlying driver of the chronic otitis that predisposes to Pseudomonas
• Regular ear examinations for predisposed breeds before chronic damage is established
• Avoid unnecessary antibiotic use: broad-spectrum antibiotics without culture select for resistant organisms
• Prompt treatment of early otitis: shallow infections before biofilm establishes are far easier to treat than chronic, deep infections

Frequently asked questions

My dog has been treated for ear infections many times and they keep coming back. Could it be Pseudomonas?

Very possibly. Recurring ear infections that do not respond to standard antibiotics, or that initially improve but always return, are a classic Pseudomonas pattern. Ask your vet to perform cytology and culture on the next flare rather than prescribing empirically. Identifying Pseudomonas and getting susceptibility results changes the entire treatment approach.

Can Pseudomonas spread from my dog to me?

Yes, though transmission to immunocompetent adults is uncommon. MDPI (otitis study): "Multidrug-resistant P. aeruginosa can be transmitted from the pet to the owner and cause human infections in the ears, eyes, or respiratory or urinary tracts." Immunocompromised people, young children, and elderly individuals are at higher risk. Standard hygiene (handwashing after handling ear discharge, not sharing towels) significantly reduces risk.

Why does my dog's Pseudomonas ear infection smell so bad?

P. aeruginosa produces pyocyanin (a blue-green pigment with a characteristic chemical odor) and enzymes that break down tissue. The combination of pus, dying tissue, and bacterial metabolic products creates the distinctive smell. The intensity of the odor correlates with the severity of the infection and the degree of tissue destruction.

How long does Pseudomonas otitis treatment take?

Significantly longer than simple bacterial ear infections. Effective Pseudomonas otitis treatment typically requires 6 to 12 weeks of consistent topical treatment, regular ear cleaning, and often systemic antibiotics. The allergy underlying the chronic otitis must also be managed if the allergic inflammation is not controlled, the infection will recur regardless of antibiotic treatment.

Can I use human ear drops for my dog's Pseudomonas ear infection?

No. Human ear formulations are not designed for canine ear anatomy, do not achieve appropriate drug concentrations in the deeper canine ear canal, and are not labeled for veterinary use. More importantly, using any antibiotic-containing product without culture confirmation wastes time and may select for resistance. Always use veterinary-prescribed products based on culture results.

Is Pseudomonas in a dog's ear an emergency?

Not typically for uncomplicated otitis externa. However, if your dog is in severe pain, cannot open its mouth, has neurological signs (head tilt, falling, circling), or if the discharge has suddenly increased dramatically, seek same-day veterinary assessment. These signs suggest spread to the middle or inner ear (otitis media or interna), which is a more serious situation.

Resources

• DVM360. Treatment of Pseudomonas Otitis in the Dog. dvm360.com
• MDPI Microorganisms (2023). Pseudomonas spp. in Canine Otitis Externa. mdpi.com
• VetCareNews. Pseudomonas Ear Infection in Dogs: Symptoms and Treatment. vetcarenews.com
• VetInfo. Pseudomonas Infection in Dogs. vetinfo.com
• PMC (2021). Characterization of Canine Otitis Externa Pseudomonas aeruginosa Isolates. ncbi.nlm.nih.gov

It looks like care. It feels like instinct. But when a dog licks an infected wound, they are almost always making it worse.

Understanding why dogs do it, and what actually happens to the wound when they do, is the foundation for preventing it effectively.

Quick answer: Dogs lick wounds because of deep-rooted instinct tied to pain relief, self-cleaning, and the mild antibacterial properties of saliva. But dog saliva also contains Pasteurella, Staphylococcus, and other bacteria that worsen infections, cause tissue damage, and can reopen healing wounds. For infected wounds especially, licking is harmful and must be prevented consistently.

Key takeaways

• Licking is instinctive, not deliberate harm: Dogs are not doing something wrong. The behavior is hardwired.
• Dog saliva has mild antibacterial properties: But those properties are no match for an established wound infection.
• Dog saliva also contains harmful bacteria: Pasteurella, Staphylococcus, and E. coli are all common in dog mouths.
• Licking causes physical damage to healing tissue: The tongue is abrasive. Repeated licking reopens wounds, removes scabs, and pulls out sutures.
• Licking infected wounds spreads bacteria: To adjacent healthy skin, and in some cases, to humans.
• Prevention must be consistent: Brief unsupervised moments are all it takes to undo days of healing.

Why dogs lick wounds: the real reasons

1. Instinct and evolution

Dogs evolved to lick wounds long before veterinary care existed.

In the wild, licking removed debris from wounds and reduced surface bacterial contamination enough to prevent immediate worsening. The behavior was reinforced because it sometimes worked.

That evolutionary programming remains intact. A dog that feels pain or discomfort in any part of their body will try to reach it with their tongue.

2. Pain relief

Licking temporarily numbs the wound area.

The act of licking overstimulates sensory nerves, which can briefly override pain signals sent to the brain. It is the same mechanism behind rubbing a bruise: the sensation of the rub drowns out the pain signal.

This is why dogs with infected wounds are particularly persistent lickers. Infection causes real discomfort, and licking provides short-term relief. The problem is that each episode of relief worsens the underlying problem.

3. Scent detection

Dogs have an extraordinarily powerful sense of smell.

An infected wound produces strong, distinct odors from bacterial metabolic activity and tissue breakdown. Dogs are drawn to investigate and respond to these odors instinctively.

The worse the infection smells, the more attracted the dog is likely to be.

4. Cleaning behavior

Dogs use their mouths to groom and clean themselves and others.

Mothers lick puppies from birth. Dogs lick each other as a social bonding behavior. Licking a wound is a natural extension of this cleaning instinct.

The problem is that a dog's mouth, while somewhat self-regulating, is far from sterile.

The truth about dog saliva and wound healing

What saliva can do

Dog saliva does contain compounds with genuine antibacterial effects:

• Lysozyme: An enzyme that can damage bacterial cell walls
• Lactoferrin: A protein with mild antimicrobial properties
• Defensins: Small proteins involved in immune defense

Some studies have confirmed limited antibacterial activity against specific bacteria. Ancient cultures, including the Egyptians and Greeks, believed dog saliva had healing properties, and there was some biological basis for that belief.

What saliva cannot do

These mild antibacterial properties cannot:

• Clear an established wound infection
• Outpace the bacteria being continuously re-introduced with each lick
• Replace saline cleaning, antiseptics, or antibiotics

And critically, dog saliva also contains a long list of bacteria that can cause infection, not just fight it.

The bacteria in a dog's mouth

A dog's oral cavity contains hundreds of bacterial species. Several are particularly concerning for wound health:

Every time a dog licks an infected wound, these bacteria are deposited directly onto already-compromised tissue.

In an infected wound, the skin barrier is partially broken. Bacteria gain access not just to the surface but to deeper tissue layers.

What licking actually does to a wound

The physical and biological effects of licking on a wound:

Physically:

• The tongue is rough and abrasive, disrupting fragile granulation tissue
• Repeated licking reopens healing tissue and scabs
• Sutures can be pulled loose or removed entirely
• Wound edges that were closing are separated again

Biologically:

• New bacteria are introduced with every lick
• Moisture from saliva creates a favorable environment for bacterial growth
• The inflammatory response is repeatedly re-triggered
• Healing tissue does not progress past the early repair stage

A wound that a dog is allowed to lick does not heal. It cycles repeatedly through injury and early inflammation without ever reaching the repair stage.

The particular risk with infected wounds

A wound that is already infected has a partially disrupted skin barrier. Bacteria from the dog's saliva have a direct pathway into deeper tissue.

This matters because:

1. An existing infection makes tissue more vulnerable to secondary bacterial colonization
2. Different bacterial species from the mouth can establish alongside the original infection
3. Antibiotic-resistant bacteria from the dog's skin and mouth, including MRSP, can be introduced
4. Repeated licking prevents the immune system from getting the wound under control

The result: A wound that might have responded to a standard antibiotic course becomes polymicrobial and harder to treat.

Why licking prevention is non-negotiable

Owners sometimes underestimate how much damage a single licking session causes, or rationalize that a little licking is fine.

It is not fine on an infected wound. Here is what brief unsupervised access can do:

• Remove two to three days of granulation tissue growth
• Reopen a wound that was beginning to close
• Pull out a suture, creating an entry point for deeper infection
• Shift a manageable localized infection toward a spreading one

For proper wound treatment instead of licking, including the correct cleaning products, step-by-step home care protocol, and when to escalate to veterinary treatment, that guide covers every treatment decision clearly.

How to stop a dog from licking wounds

E-collar (cone)

The most reliable tool when fitted and used correctly.

Fitting requirements:

• Must extend at least 2 inches past the tip of the nose
• Shorter cones allow flexible dogs to still access wounds
• Must be worn at all times, including overnight

Recovery suits and body wraps

For trunk and abdominal wounds, a well-fitted recovery suit covers the wound without pressure.

Some dogs tolerate suits better than cones. The key requirement is that the suit actually prevents access. Test it by observing whether your dog can reach the wound when wearing it.

Soft recovery collars

Inflatable or padded collars are more comfortable for many dogs than rigid plastic cones.

Confirm the soft collar prevents your specific dog from accessing the specific wound. Flexibility varies by dog size and wound location.

What does not work reliably

For how to tell if a wound is infected before deciding how aggressively to prevent licking, knowing the severity of infection helps you understand the urgency of prevention.

When licking has already caused damage

Signs that licking has disrupted healing:

• Wound appears larger, rawer, or more inflamed than the previous day
• Scabbing that was forming has been removed
• Sutures appear loosened, pulled, or missing
• Discharge has returned or increased after improving
• A previously healing wound shows spreading redness

If licking has caused visible wound damage, contact your veterinarian. Depending on the extent, you may need suture repair, wound re-evaluation, or an adjusted antibiotic plan.

For understanding how licking delays wound healing stages and which healing phase is most disrupted by licking activity, that guide explains how each stage is specifically affected.

Frequently asked questions

Is it true that dog saliva heals wounds?

Partially true but significantly overstated. Dog saliva contains some antibacterial compounds. However, it also contains bacteria that cause infection, and the physical action of licking causes tissue damage. For infected wounds, the harms far outweigh any modest antibacterial benefit.

My dog seems to be licking to soothe pain. Should I let them?

No. The temporary pain relief from licking comes at the cost of worsening infection and delayed healing. Address the underlying pain through your veterinarian: appropriate pain medication manages discomfort more effectively and safely than licking.

Can my dog's licking infect me?

Yes, in some circumstances. Several bacteria common in dog saliva, including Pasteurella and Capnocytophaga, can infect humans. The risk is highest for immunocompromised individuals, elderly people, and anyone with open wounds. Avoid allowing a dog to lick open wounds on your skin.

How long does the E-collar need to stay on?

Until your veterinarian confirms at the follow-up appointment that the wound is sufficiently healed. For infected wounds, this is typically longer than for clean surgical wounds. When in doubt, leave it on.

My dog keeps removing the cone. What can I do?

Try a different style: soft inflatable collars or recovery suits are often tolerated better. If your dog is genuinely distressed by all barriers, ask your vet about mild short-term sedation for the recovery period in severe cases.

For safe alternatives to licking and what you can apply to wounds instead that genuinely supports healing, that guide covers what evidence-based home wound care actually looks like.

The instinct to lick a wound is one of the oldest behaviors in dogs. The problem is that it evolved for a world without established wound infections and without the bacterial loads modern dogs carry. On an infected wound, licking is one of the most consistent causes of prolonged healing and treatment failure. Stopping it is not optional.

Resources

The following sources were used as reference and background for this article:

• PetMD. Why Dogs Lick Their Wounds and How to Stop Them. petmd.com
• American Kennel Club. Should Dogs Lick Wounds? How Saliva Affects Wound Healing. akc.org
• AskAVet. Why Do Dogs Lick Wounds? Vet Insights and Safety Tips. askavet.com
• The Kennel Club. Why Do Dogs Lick Their Wounds? royalkennelclub.com
• Adopt A Pet. Why Does My Dog Lick My Wounds? adoptapet.com

Not all surgical wound infections respond to the same antibiotic. Which drug works, how long to give it, and whether oral or injectable delivery is needed all depend on what bacteria is causing the infection, how deep it is, and what the sensitivity test shows.

Starting the wrong antibiotic in a resistant infection wastes time, delays healing, and selects for more resistance. Getting it right from the start requires a culture result.

Quick answer: Antibiotic selection for surgical wound infections in dogs must be guided by bacterial culture and sensitivity testing, not empiric choice based on appearance. For susceptible S. pseudintermedius infections, first-line options include cephalexin or amoxicillin-clavulanate. For MRSP infections, options shift to chloramphenicol, potentiated sulfonamides, rifampicin (always in combination), or amikacin based on the sensitivity panel. Treatment continues at minimum 21 days or one week past clinical resolution per DVM360 surgical guidance.

Key takeaways

• Culture and sensitivity testing before antibiotics is the non-negotiable first step for any wound that isn't responding to treatment.
• Beta-lactams (amoxicillin, cephalexin) are appropriate for susceptible staph: not for MRSP, where they are always ineffective.
• MRSP shifts options to chloramphenicol, potentiated sulfonamides, rifampicin, or amikacin based on sensitivity.
• DVM360 surgical guidance: systemic antimicrobials given at least one week beyond clinical remission, minimum 21 days.
• Deep wound infections and bone involvement require IV or injectable antibiotics for adequate tissue penetration.
• Topical antiseptic wound care is not optional: it's the foundation of wound infection management alongside any antibiotic.

Why culture always comes first

The cost of guessing wrong

A surgical wound infection that doesn't respond to the antibiotic prescribed is not just a treatment failure: it's an active delay in a dog's recovery, and it applies selection pressure that drives bacteria toward more resistance.

DVM360's surgical wound infection guidance (Dr. Karen Tobias, ACVS) is direct: "Repeated antimicrobial exposure at subtherapeutic concentrations or inappropriately short duration may select for resistance." Starting the wrong antibiotic and then adjusting later means the wrong antibiotic was applied for the time it took to recognize failure.

What culture provides that appearance cannot

A wound that looks infected tells you: infection is present. It tells you nothing about which bacteria is causing it or which antibiotics will work against it.

Culture and sensitivity testing provides:

• Species identification (is this S. pseudintermedius, E. coli, Pseudomonas, or another organism?)
• Methicillin resistance status (is it MRSP or susceptible staph?)
• Full susceptibility panel (which specific antibiotics retain activity against this isolate)

Without this, antibiotic selection is a guess. For susceptible staph, the guess is sometimes right. For MRSP, it is almost always wrong.

Antibiotic options for susceptible surgical wound infections

First-line oral options (susceptible S. pseudintermedius)

For deep or severe susceptible infections (injectable)

Treatment duration for susceptible infections

• Superficial wound infection: 3 to 4 weeks minimum; 7 to 10 days past clinical resolution
• Deep wound infection: 6 to 8 weeks; continue until 2 weeks past complete resolution
• Minimum surgical guidance: 21 days with at least one week past remission of clinical disease (DVM360 / Dr. Karen Tobias)

Antibiotic options for MRSP surgical wound infections

Beta-lactam antibiotics are always ineffective against MRSP. This includes cephalexin, amoxicillin, amoxicillin-clavulanate, cefpodoxime, and all other penicillins and cephalosporins.

DVM360 (Dr. Karen Tobias) data from clinical practice: MRSP is usually susceptible to chloramphenicol (100%) or aminoglycosides (97%).

Culture-guided MRSP options

Duration for MRSP wound infections

• Superficial MRSP wound: minimum 3 to 4 weeks; topical therapy throughout
• Deep MRSP wound: 8 to 12 weeks; continue 2 weeks past complete clinical resolution
• Implant-associated MRSP: indefinite suppression or surgical removal; antibiotics alone rarely cure biofilm infection

For full MRSP-specific antibiotic guidance, see full MRSP antibiotic guidance. For how MRSP resistance makes these decisions necessary, see resistance mechanism behind these choices.

When IV antibiotics are needed

Injectable or IV antibiotics are appropriate when:

• The dog is systemically ill (fever, severe lethargy, inappetence beyond 48 hours post-surgery)
• Deep tissue infection with bone involvement (osteomyelitis)
• Oral antibiotics cannot achieve adequate tissue concentrations
• The dog cannot take oral medications reliably

The SustainableVet antibiotics reference confirms: "In more serious infections, such as deep tissue abscesses, bone involvement, or systemic signs: IV antibiotics are required for faster and stronger action."

Common IV options for severe surgical wound infections:

• Cefazolin: first-choice IV beta-lactam for susceptible infections
• Carbapenems (imipenem): last-resort option for resistant hospital-acquired mixed infections
• Enrofloxacin (IV or injectable): gram-negative coverage; not for MRSP

Topical treatment alongside antibiotics

Antibiotics address systemic or deep bacterial load. Topical antiseptic treatment addresses surface bacterial load and biofilm, a separate and essential component of wound management.

During active MRSP wound infection:

• Wound lavage with dilute chlorhexidine (0.05%) or sterile saline: once to twice daily
• Chlorhexidine-impregnated dressings between lavage sessions
• Mupirocin ointment for localized wound margins
• Silver-based dressings for biofilm-prone or chronic wounds

DVM360 guidance from Dr. Tobias: "In some patients, topical wound therapy is sufficient to clear the infection", and in others it is the essential companion to systemic treatment.

For post-surgical infection context, see post-surgical infections and antibiotic role.

Monitoring during antibiotic treatment

Clinical monitoring

• Wound appearance should improve within 5 to 7 days of starting an appropriate antibiotic
• No improvement at 7 to 10 days is the indication to reassess and culture if not already done
• Improvement then relapse suggests too-short a course, premature antibiotic discontinuation, or biofilm involvement

Laboratory monitoring

• Culture recheck: repeat culture during treatment if progress is unexpectedly slow; repeat 2 weeks after completing antibiotics to confirm microbiological clearance
• Blood work for long-course antibiotics: renal function monitoring for amikacin; bone marrow assessment for long chloramphenicol courses

For how to recognize when infections are progressing or resolving after surgery, see signs of resolving vs. worsening infection.

Common antibiotic mistakes in surgical wound infections

Starting antibiotics before culturing

If the wound is infected, culture before starting antibiotics whenever possible. Post-antibiotic cultures are harder to interpret. If antibiotics must be started urgently (systemically ill dog), culture the wound before the first dose is given.

Using beta-lactams empirically for suspected MRSP

If a dog has received multiple prior antibiotic courses, has a history of MRSP, or the infection isn't responding to a beta-lactam already, do not add another beta-lactam. Culture first.

Stopping antibiotics when the wound "looks better"

Wounds look better before they are microbiologically clear. The bacteria below the visible surface level still need to be eliminated. Stopping at apparent visual resolution is the most common cause of relapse.

Using rifampicin as monotherapy

Rifampicin resistance develops rapidly when used alone. It must always be combined with another antibiotic that the organism is susceptible to, per sensitivity results.

For the broader MRSP treatment strategy, see MRSP treatment strategy. For how biofilm affects antibiotic effectiveness in wounds, see biofilm and antibiotic effectiveness.

Frequently asked questions

My dog's wound infection isn't getting better after 10 days of cephalexin. What now?

Request a culture and sensitivity test before any antibiotic change. If MRSP is confirmed, cephalexin has zero effect: every additional day of ineffective treatment allows the infection to progress while also applying selection pressure. If culture was not done at the start of treatment, now is the time.

My dog needs long-term chloramphenicol for MRSP. Is that safe?

Chloramphenicol carries a risk of dose-dependent bone marrow suppression with prolonged use. Your vet should monitor a complete blood count (CBC) at intervals during treatment, typically every 2 to 3 weeks. The risk-benefit calculation favors use in MRSP cases where other options are unavailable, but monitoring is not optional for extended courses.

Can I give my dog human antibiotics from the pharmacy for a wound infection?

No. Several human antibiotic formulations contain ingredients (xylitol in some liquids, for example) that are toxic to dogs. Veterinary formulations are dosed differently than human preparations. Most critically, you cannot know which antibiotic is appropriate without a culture result. Using the wrong antibiotic, whether from a pharmacy or leftover from a prior prescription, delays appropriate treatment.

Antibiotic selection for surgical wound infections is not a guessing game. The pathogen determines which drugs work, and only culture testing identifies the pathogen reliably. Getting that result first, selecting based on it, running the full course, and pairing systemic treatment with topical wound care is the complete approach.

Resources

• DVM360 (Dr. Karen Tobias, ACVS). Surgery STAT: Managing methicillin-resistant wound infections. dvm360.com
• Clinician's Brief. Clinical Suite: MRSP Infections in Dogs & Cats. cliniciansbrief.com
• ISCAID. Antimicrobial use guidelines for canine pyoderma. PMC, 2025. ncbi.nlm.nih.gov

Enterococcus faecalis is a normal inhabitant of your dog's gastrointestinal tract. In healthy dogs, it causes no problems. The trouble starts when this opportunistic bacterium moves from where it belongs into tissue where it does not urinary tracts, wounds, surgical sites, and bloodstream.

What makes E. faecalis clinically significant is not just where it ends up, but how resistant it is once it gets there.

Quick answer: Dogs get Enterococcus faecalis from their own gut flora, spreading to the urinary tract or wounds via fecal contamination. It is the top Enterococcus in canine UTIs and is highly antibiotic resistant. Culture testing is essential.

Key takeaways

• E. faecalis is a normal gut commensal; infections occur when it migrates to the urinary tract, wounds, or bloodstream
• Fecal contamination is the primary route: UTI-causing E. faecalis originates from the dog's own stool microflora
• E. faecalis is the most common Enterococcus in canine UTIs: one study found it in 68% of canine Enterococcus isolates
• High antibiotic resistance is the defining clinical challenge: 74.5% resistant to enrofloxacin, 84.3% to clindamycin
• Dogs can transmit resistant E. faecalis to humans; immunocompromised owners are particularly at risk
• Culture and sensitivity testing is essential: empirical antibiotic treatment without testing frequently fails

What is Enterococcus faecalis?

Enterococcus faecalis is a Gram-positive, facultatively anaerobic bacterium that naturally colonizes the gastrointestinal tracts of most mammals, including dogs and humans. Veterian Key (Sykes): "In healthy dogs and cats, enterococci can be found on the skin and within the oral cavity, nasal cavity, and gastrointestinal tract."

It belongs to a group of bacteria once called "Group D Streptococci" and is now classified separately. Enterococci are remarkably resilient: they tolerate a wide range of temperatures, salt concentrations, and pH levels, allowing them to persist on surfaces and in environments where most bacteria cannot survive.

E. faecalis vs. E. faecium: Both are common in dogs, but they are not equivalent. The peer-reviewed UTI study (MDPI Animals, 2021) found: "E. faecalis predominated among UTI isolates... E. faecalis seems to be more virulent than E. faecium, justifying its more frequent involvement in urinary tract infections." E. faecalis carries more virulence genes, including those enabling biofilm formation.

How dogs acquire E. faecalis infections

From their own gut flora

The most common route. The MDPI study confirmed: "Our data confirm that enterococci inhabitant of the gut flora probably represent the main source of UTI in dogs."

When E. faecalis from fecal matter contacts the urethral opening, the bacteria can ascend into the bladder. This is particularly common in:

• Female dogs: shorter urethra provides a shorter path for bacteria to ascend
• Dogs that groom after defecation: licking the perineal area transfers gut bacteria to nearby surfaces
• Dogs with incontinence or urinary retention: stagnant urine is a bacterial growth medium

Environmental exposure

E. faecalis survives in soil, water, and on surfaces for extended periods. Kennels, veterinary clinics, dog parks, shared water bowls, and poorly sanitized equipment can all harbor the organism. Veterian Key: "Mode of transmission: direct contact. Organisms are usually commensals that invade opportunistically."

Nosocomial (hospital-acquired) infections are a documented concern: dogs recovering from surgery in veterinary hospitals can acquire E. faecalis from contaminated surfaces or instruments.

Surgical sites and wound infections

Any break in the skin or mucosal surface is a potential entry point. Post-surgical wound infections with E. faecalis occur when fecal or environmental bacteria contaminate the surgical site during recovery most commonly abdominal surgeries where the gastrointestinal tract is opened, or perineal surgeries near the rectum.

Veterian Key lists the full spectrum of clinical presentations: "Major clinical signs include neonatal septicemia, urinary tract infections, postoperative incision or wound infections, otitis externa, bacteremia and endocarditis."

Which dogs are most at risk?

Dogs with existing urinary tract disease

Clinician's Brief (UTI study): "55% of dogs infected with Enterococcus spp in the urinary tract were presented with LUT signs... up to 45% of cases may have been subclinical." Dogs with structural urinary abnormalities, bladder stones, or indwelling catheters have significantly elevated risk.

Immunocompromised dogs

Dogs on long-term corticosteroids, chemotherapy, or with conditions like Cushing's disease or diabetes have impaired immune defenses that allow normally harmless gut commensals to establish infection.

Post-surgical patients

Any surgery involving the abdomen, perineal area, or urinary tract creates pathways for E. faecalis to access normally sterile tissue. Dogs with urinary catheters are at particular risk.

Dogs on prior antibiotics

Prior antibiotic treatment eliminates susceptible bacteria and creates ecological space for resistant E. faecalis to proliferate. This is one reason E. faecalis is disproportionately found in dogs that have received previous antibiotic courses.

Where E. faecalis causes infection in dogs

Urinary tract infections (UTIs)

The most common clinical presentation. Dogs with E. faecalis UTI may show:

• Frequent urination (pollakiuria)
• Straining to urinate (stranguria)
• Blood in urine (hematuria)
• Genital licking
• Accidents in the house
• Sometimes no signs at all (subclinical bacteriuria)

Clinician's Brief: "Enterococcus spp bacteriuria could serve as a marker of underlying LUT inflammation."

Wound and surgical site infections

Recognized by: poor wound healing, increasing discharge, redness extending from the wound, pain at the site, and odor.

Bacteremia and endocarditis

Severe systemic infection when E. faecalis enters the bloodstream. Associated with fever, lethargy, and in the case of endocarditis, heart murmur development. Veterian Key confirms this clinical spectrum in dogs.

For how E. faecalis contributes to severe wound infections including necrotizing fasciitis, see Enterococcus in severe wound infections.

The antibiotic resistance challenge

This is the defining clinical concern with E. faecalis. The MDPI 2021 study of canine isolates found alarming resistance rates:

• Enrofloxacin (fluoroquinolone): 74.5% resistant
• Clindamycin: 84.3% resistant
• Tetracycline: 78.4% resistant
• Ampicillin: 64.7% resistant (MIC ≥ 64 µg/mL in 47.1% of isolates)

E. faecalis has intrinsic resistance to cephalosporins, lincosamides, and low-level resistance to aminoglycosides. It can also acquire high-level resistance to aminoglycosides (HLAR phenotype) found in 47.1% of isolates in the study.

What this means in practice: empirical antibiotic treatment (prescribing without culture results) for E. faecalis infections has a high probability of failure. Culture and sensitivity testing is not optional it is essential for selecting an antibiotic with a reasonable chance of working.

Effective options (subject to susceptibility results) include nitrofurantoin (for uncomplicated UTI), linezolid, or ampicillin when susceptibility is confirmed. Vancomycin resistance was not detected in the MDPI study this is an important distinction from some human E. faecalis strains.

Zoonotic risk: can E. faecalis pass from dogs to humans?

Yes. The Korean resistance study confirmed: "Companion animals treated with antibiotics in an intensive care unit were a source for the zoonotic transmission of MDR Enterococcus." The MDPI study: "Infected dogs may be a source of Enterococcus spp. for their owners who, mainly in case of immunocompromised persons, can develop severe pathologies."

Practical guidance:

• Wash hands after handling a dog with a known E. faecalis infection
• Clean and disinfect wound dressings and surfaces that contact discharge
• Immunocompromised household members (chemotherapy patients, transplant recipients, those with HIV) should discuss additional precautions with their physician
• There is no need to remove a dog from the home in most circumstances, but hygiene is essential

For how resistant organisms like Pseudomonas relate to the same clinical picture of treatment-resistant infections, see other resistant organisms alongside Enterococcus. For how antimicrobial prophylaxis relates to Enterococcus in surgical patients, see antimicrobial prophylaxis against Enterococcus.

Diagnosis and treatment

Diagnosis: urine culture with colony count (for UTI); wound swab culture for wound infections. Sensitivity testing is required for every case.

Treatment:

• Antibiotic selection guided entirely by culture and sensitivity results
• Duration: typically 4 to 6 weeks for UTI; longer for systemic infection
• Recurrent UTI requires investigation for underlying structural, hormonal, or immune causes
• Wound infections require drainage, debridement, and wound care alongside antibiotics

Prevention:

• Prompt treatment of any wound or surgical site
• Post-surgical monitoring for early infection signs
• Judicious antibiotic use (avoiding unnecessary courses that select for resistance)
• Hygiene in multi-dog environments and kennels

Frequently asked questions

Is Enterococcus faecalis in a dog's urine always an infection?

Not necessarily. Subclinical bacteriuria (bacteria in urine without clinical signs) exists. Clinician's Brief: up to 45% of dogs with enterococcal bacteriuria may have no lower urinary tract signs. Whether to treat depends on the dog's clinical presentation, the species identified, and whether underlying disease predisposes to ascending infection. Your vet will interpret the culture result in the context of the full clinical picture.

My dog was prescribed a fluoroquinolone for an E. faecalis UTI. Is that appropriate?

Potentially problematic. The MDPI study found 74.5% of canine E. faecalis isolates were resistant to enrofloxacin. A fluoroquinolone should only be used if the sensitivity test shows susceptibility. If your dog was prescribed one empirically (before culture results), follow up with your vet when results are available and ask whether the antibiotic needs to be changed.

Can E. faecalis cause a UTI to keep coming back?

Yes. Recurrent E. faecalis UTIs occur for several reasons: antibiotic treatment that did not fully clear the infection, structural abnormalities (bladder stones, ectopic ureters, tumors) that maintain bacterial colonization, inadequate treatment duration, or reinfection from the dog's own gut flora. A full urological workup (imaging, repeat culture) is appropriate for any dog with more than two UTIs per year.

How long does E. faecalis survive on surfaces?

Enterococci are notably hardy. They can survive on environmental surfaces for days to weeks. This is why shared water bowls, bedding, and poorly sanitized kennel runs can serve as transmission sources. Regular cleaning with disinfectants effective against Gram-positive bacteria reduces this risk.

My dog has no symptoms but E. faecalis was found in a urine sample. What should I do?

Discuss with your vet whether treatment is indicated. In dogs without clinical signs and no predisposing conditions, subclinical bacteriuria may not require antibiotic treatment treating asymptomatic bacteriuria can select for resistance without clinical benefit. Your vet will weigh the evidence for your dog specifically.

Is there a vaccine against E. faecalis for dogs?

No vaccine currently exists for E. faecalis in dogs. Prevention relies on hygiene management, judicious antibiotic use, prompt wound treatment, and monitoring for early infection signs in high-risk dogs.

Resources

• MDPI Animals (2021). Characterization and Comparison of Enterococcus spp. Isolates from Feces of Healthy Dogs and Urine of Dogs with UTIs. mdpi.com
• Veterian Key (Sykes). Streptococcal and Enterococcal Infections. veteriankey.com
• Clinician's Brief. Risk Factors for Enterococcal Bacteriuria in Dogs. cliniciansbrief.com
• PMC (2021). Antimicrobial Resistance Profiles of E. faecium and E. faecalis from Healthy Dogs and Cats. ncbi.nlm.nih.gov